Manage Your Liver
Q:

A more effective liver protection approach than drugs

A more effective liver protection approach than drugs
A:

Currently, the most common liver diseases affecting our society include: viral hepatitis B/C, fatty liver, non-alcoholic fatty liver disease, NASH, cirrhosis and liver cancer. [1]Drugs for each of these diseases have their downside and shortcomings, such as high treatment costs (Hepatitis C), low success rate (interferon for Hepatitis B/C), long treatment duration (Hepatitis B). Moreover, some liver diseases such as NASH, non-alcoholic fatty liver disease and cirrhosis do not even have any treatment options.

 

Failure to attack the liver diseases mentioned above has lead to the continuous increase in deaths caused by liver cancer [2] increase in the number of people in need of liver transplants, as well as social issues like rise in expenditure in national health care.

To change the situation, we must arouse the public’s awareness of liver protection and prevention of liver diseases, and we must find a more effective approach than drugs.

 

At the International Conference on Traditional Medicine held in February 2013, WHO Director-General, Dr Margaret Chan stated that “Traditional medicines of proven quality, safety, and efficacy, contribute to the goal of ensuring that all people have access to care,” [3]

 

Dr Chan has her point. Proper use of traditional medicine can not only help to strengthen the body’s self-healing capabilities, but also prevent diseases. The use of traditional medicine for liver protection and prevention of liver diseases and liver cancer is becoming a trend as it has lower toxicity and higher effectiveness.

 

Dr Margaret Chan further explained: “The affordability of most traditional medicines makes them all the more attractive at a time of soaring health-care costs and nearly universal austerity. Traditional medicine also stands out as a way of coping with the relentless rise of chronic non-communicable diseases.” (Including fatty liver disease, NASH, and liver cirrhosis)

 

In fact, there are already some scientifically proven and safe traditional medicines available in the market with significant liver protection and liver function enhancement effects. [4][5]  While waiting for the arrival of new drugs, liver disease patients may find it useful to learn more about liver health maintenance and the advantages of traditional medicine. In order to improve health, and to reduce the occurrence of liver diseases, we must consider all treatment options available, and raise the awareness of health protection and disease prevention.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us